Wireless MicroPremVitals Button Sensor for the NICU
Official title: Miniaturized Vital Sign Monitoring for Preterm Infants in the Neonatal Intensive Care Unit
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT07732257 · Data updated 2026-11-12
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | June 19, 2026 |
| Main results expected | January 30, 2027 |
| Study ends | March 30, 2027 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07732257 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants in the NICU born at 22+0 to 29+6 weeks, at least 72 hours old, clinically stable, and with agreement from the healthcare team and family.
✕Probably not a fit
Very unstable infants or those with skin conditions or other risks may not benefit from the wireless sensor approach and may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the feasibility, safety, and accuracy of the Wireless MicroPremVitals Button Sensor System for use in extremely preterm neonates in the NICU. The sensors provide continuous ECG, SpO2, and skin temperature readings while aiming to reduce wires and improve skin contact with parents. The project builds on prior work in skin-integrated, soft electronics designed for fragile neonatal skin. It also surveys parent and healthcare provider perspectives on standard and wireless monitoring in very preterm infants. Eligibility includes infants born between 22+0 and 29+6 weeks who are at least 72 hours old and clinically stable, with parental and clinical team agreement to participate.
Why it matters
Potential benefit: If successful, the system could offer safer, more comfortable, and more parent-involved monitoring for extremely preterm infants by reducing wires and improving mobility.
How similar studies have gone: Prior work in skin-integrated, wireless neonatal monitoring has shown promise in reducing wires and improving comfort, though this exact sensor system is being tested in a small, specific preterm population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants admitted to the NICU with a gestational age of ≥ 22+0 weeks and ≤ 29+6 weeks at birth, * AND \>72h of age at time of study, * AND clinically stable, * AND with the Neonatal Nurse Practitioner (i.e., NNP) and Healthcare Team in agreement for the patient to participate in the study. Exclusion Criteria: * Infants with a skin abnormality that would potentially increase the risk of injury, * patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment. * Infants admitted to the NICU with a gestational age of \< 22+0 weeks or \> 29+6 weeks at birth, * and/or ≤ 72h of age at time of study, * and/or not meeting all requirements of clinical stability, * and/or with the Neonatal Nurse Practitioner (i.e., NNP)/Healthcare Team in disagreement for the patient to participate in the study.
Where it's running
-
Montreal Children's Hospital
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Guilherme Sant'Anna, MD, PhD — The Research Institute of the McGill University Health Center
- Study coordinator: Alyssa Maximov
- Email: alyssa.maximov@muhc.mcgill.ca
- Phone: 5149341934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
Caffeine citrate loading dose before extubation in preterm infants
This study tests if giving a dose of caffeine to preterm babies before they are taken off the ventilator can help them breathe better and stay off the machine successfully.
-
Sedation Methods in PTBD: How Two Regimens Compare for Quality and Recovery
This study tests two sedation plans (propofol with remifentanil vs propofol with ketamine) to see which helps patients recover faster after PTBD while staying comfortable and safe.
-
Impact of a Multicomponent Exercise Program on Function in Frail Adults in Intermediate Care
A randomized trial tests whether a personalized multicomponent exercise program can improve function and reduce frailty in adults admitted to an intermediate care hospital.
-
Detection of Respiratory Events in Extremely Preterm Infants Using Acoustic Monitoring
A new acoustic monitoring approach is being tested to detect breathing problems in very preterm babies to help NICU teams spot and manage apnea and related events.
-
Neonatal data and biobank to understand what influences development in very preterm infants
This project will collect clinical information and biological samples to see if early biological, clinical, and environmental factors predict short- and long-term development in infants born before 32 weeks or under 1500 g.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.